NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/31/2026
Back to search
Official data from USPTO
RADIONETICS ONCOLOGY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
RADIONETICS ONCOLOGY
ST13
US500000097085639Class
5, 42
Filing
97085639
Registration
8196391
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
03/31/2026
Trademark type
Word
Nice classes
5, 42
Filing date
10/21/2021
Registration date
03/31/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/31/2026
Last transaction
03/31/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
02/10/2026
First use in commerce
02/10/2026
Drawing code
4
Owner type
03
Owner location
San Diego, CA, US
Examiner
SHANOSKI, JOANNA MARIE
Law office
O30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Radionetics Oncology, Inc.
Radionetics Oncology, Inc.
Representatives
Caitlin Byczko BARNES & THORNBURG LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in treating endocrine disorders and endocrine-related cancers; pharmaceutical preparations for the treatment or prevention of dermatologicalcardiovascularhematologicalbonerespiratorycentral nervous systemendocrinologicalcirculatorygastroenterologicaldigestivehormonaldiabeticmuscularrheumaticimmune systemocular and metabolic diseases and disorders; diagnostic radiopharmaceutical preparations; radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer
Class 42
medical and pharmaceutical research services; pharmaceutical research and development; medical research for use in oncology; medical research services in the field of radiopharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals; medical and scientific researchconducting clinical trials for others
Publications
History of USPTO decisions and trademark events.
43 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/31/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/12/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/12/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/11/2026
IUAF
USE AMENDMENT FILED
03/04/2026
EISU
TEAS STATEMENT OF USE RECEIVED
03/03/2026
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/21/2025
EX5G
SOU EXTENSION 5 GRANTED
08/21/2025
EEXT
SOU TEAS EXTENSION RECEIVED
08/18/2025
EXT5
SOU EXTENSION 5 FILED
08/17/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/28/2025
EX4G
SOU EXTENSION 4 GRANTED
01/28/2025
EXT4
SOU EXTENSION 4 FILED
01/08/2025
EEXT
SOU TEAS EXTENSION RECEIVED
01/08/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/10/2024
EX3G
SOU EXTENSION 3 GRANTED
07/10/2024
EXT3
SOU EXTENSION 3 FILED
07/10/2024
EEXT
SOU TEAS EXTENSION RECEIVED
07/10/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/11/2024
EX2G
SOU EXTENSION 2 GRANTED
01/09/2024
EXT2
SOU EXTENSION 2 FILED
01/09/2024
EEXT
SOU TEAS EXTENSION RECEIVED
01/09/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/19/2023
EX1G
SOU EXTENSION 1 GRANTED
09/18/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/18/2023
EXT1
SOU EXTENSION 1 FILED
09/07/2023
EEXT
SOU TEAS EXTENSION RECEIVED
09/07/2023
DOCK
ASSIGNED TO EXAMINER
07/19/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/07/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/10/2023
PUBO
PUBLISHED FOR OPPOSITION
01/10/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/21/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/02/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/29/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/29/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/29/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/29/2022
GNRT
NON-FINAL ACTION E-MAILED
07/29/2022
CNRT
NON-FINAL ACTION WRITTEN
07/29/2022
DOCK
ASSIGNED TO EXAMINER
07/28/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/07/2021
NWAP
NEW APPLICATION ENTERED
10/25/2021
Continuous trademark protection
Get notified about every new filing that threatens RADIONETICS ONCOLOGY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.